Literature DB >> 12697653

New inhibitors of human cytomegalovirus (HCMV) on the horizon.

Erik De Clercq1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12697653     DOI： 10.1093/jac/dkg205

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

3.  Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

4.  Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Authors:  Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

Review 5.  Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.

Authors:  Mark N Prichard
Journal:  Rev Med Virol       Date:  2009-07       Impact factor: 6.989

6.  Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?

Authors:  Nada Madi; Widad Al-Nakib; Alexander Pacsa
Journal:  Adv Virol       Date:  2011-03-24

7.  Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure.

Authors:  Rafał Gawin; Erik De Clercq; Lieve Naesens; Mariola Koszytkowska-Stawińska
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.